No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".
Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Anbio Biotechnology in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
GC
Geode Capital Management, LLC
|
26.7K | 0.06% | +973 (+3.8%) | 2025 | 0.0% | |
|
Shares held by quarter
Peak holding26.7K (Q2'26)
Change over 8 quarters+26.7K
Share of the company0.060%
|
||||||
|
BO
Bank Of America Corp /de/
|
13.4K | 0.03% | NEW | Q2 '26 | 0.0% | |
|
Shares held by quarter
Peak holding13.4K (Q2'26)
Change over 8 quarters+13.4K
Share of the company0.030%
|
||||||
12 more super investors behind a free account
See every manager holding Anbio Biotechnology, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
SC
Northern Funds
|
$97.9K | 7.1K | 0.02% | 0.02% | June 30, 2026 |
Loading...